Anthony S. Fiorino, Chief Executive Officer at BRAINSTORM CELL THERAPEUTICS INC. (BCLI), bought 500 shares at $3.60 ($2K) on 2014-10-15, disclosed to the SEC on 2014-10-15.
Open-market purchase of $2k BCLI by Chief Executive Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.59 | 200 | $718 | 39.9% |
| 2 | $3.60 | 300 | $1K | 60.1% |
| Total | $3.60 avg | 500 | $2K | 100% |
| Filing → |
| BCLI | BUY | 2014-09-19 | $3K | — | Filing → |
| BCLI | BUY | 2014-09-16 | $5K | — | Filing → |